{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:36:01Z","timestamp":1747204561505,"version":"3.40.5"},"posted":{"date-parts":[[2023,2,2]]},"group-title":"In Review","reference-count":27,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,1,6]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n drug development and disease prevention of heart failure (HF) and atrial fibrillation (AF) are impeded by a lack of robust early-stage surrogates. We determined to what extent cardiac magnetic resonance (CMR) measurements act as surrogates for the development of HF or AF in healthy individuals.\nMethods\n Genetic data was sourced on the association with 22 atrial and ventricular CMR measurements. Mendelian randomization was used to determine CMR associations with atrial fibrillation (AF), heart failure (HF), non-ischemic cardiomyopathy (CMP), and dilated cardiomyopathy (DCM). Additionally, for the CMR surrogates of AF and HF, we explored their association with non-cardiac traits.\nResults\n In total we found that 9 CMR measures were associated with the development of HF, 7 with development of non-ischemic CMP, 6 with DCM, and 12 with AF. biventricular ejection fraction (EF), biventricular or end-systolic volumes (ESV) and left-ventricular (LV) end diastolic volume (EDV) were associated with all 4 cardiac outcomes. Increased LV-MVR (mass to volume ratio) affected HF (odds ratio (OR) 0.83, 95%CI 0.79; 0.88), and DCM (OR 0.26, 95%CI 0.20; 0.34. We were able to identify 9 CMR surrogates for HF and\/or AF (including LV-MVR, biventricular EDV, ESV, and right-ventricular EF) which associated with non-cardiac traits such as blood pressure, lung function traits, BMI, cardioembolic stroke, and late-onset Alzheimer\u2019s disease.\nConclusion\n CMR measurements may act as surrogate endpoints for the development of HF (including non-ischemic CMP and DCM) or AF. Additionally, we show that changes in cardiac function and structure measured through CMR, may affect diseases of other organs leading to lung disease or late-onset Alzheimer\u2019s disease.<\/p>","DOI":"10.21203\/rs.3.rs-2449265\/v1","type":"posted-content","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T18:31:17Z","timestamp":1675362677000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiac MRI to guide heart failure and atrial fibrillation drug discovery: a Mendelian randomization analysis"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-0424","authenticated-orcid":false,"given":"Amand","family":"Schmidt","sequence":"first","affiliation":[{"name":"University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-1937","authenticated-orcid":false,"given":"Chris","family":"Finan","sequence":"additional","affiliation":[{"name":"University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimount","family":"Bourfiss","sequence":"additional","affiliation":[{"name":"University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitta","family":"Velthuis","sequence":"additional","affiliation":[{"name":"University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9789-6629","authenticated-orcid":false,"given":"Esther","family":"Puyol-Ant\u00f3n","sequence":"additional","affiliation":[{"name":"University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1450-2936","authenticated-orcid":false,"given":"Abdulrahman","family":"Alasiri","sequence":"additional","affiliation":[{"name":"UMC Utrecht"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram","family":"Ruijsink","sequence":"additional","affiliation":[{"name":"University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folkert","family":"Asselbergs","sequence":"additional","affiliation":[{"name":"UCL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneline ter","family":"Riele","sequence":"additional","affiliation":[{"name":"UMCU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-7510","authenticated-orcid":false,"given":"Jessica van","family":"Setten","sequence":"additional","affiliation":[{"name":"UMCU"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"l223","DOI":"10.1136\/bmj.l223","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000\u20132017: population based cohort study","volume":"364","author":"Taylor CJ","year":"2019","unstructured":"Taylor, C. J. et al. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000\u20132017: population based cohort study. BMJ 364, l223 (2019).","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/CIRCHEARTFAILURE.110.957480","article-title":"A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction","volume":"4","author":"Lee DS","year":"2011","unstructured":"Lee, D. S. et al. A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail 4, 36\u201343 (2011).","journal-title":"Circ Heart Fail"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehaa1077","article-title":"Paradoxical impact of socioeconomic factors on outcome of atrial fibrillation in Europe: trends in incidence and mortality from atrial fibrillation","volume":"42","author":"Al-Khayatt BM","year":"2021","unstructured":"Al-Khayatt, B. M. et al. Paradoxical impact of socioeconomic factors on outcome of atrial fibrillation in Europe: trends in incidence and mortality from atrial fibrillation. European Heart Journal 42, 847\u2013857 (2021).","journal-title":"European Heart Journal"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial Fibrillation and Heart Failure","volume":"119","author":"Anter E","year":"2009","unstructured":"Anter, E., Jessup, M. & Callans, D. J. Atrial Fibrillation and Heart Failure. Circulation 119, 2516\u20132525 (2009).","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction","volume":"373","author":"Redfield MM","year":"2015","unstructured":"Redfield, M. M. et al. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. N Engl J Med 373, 2314\u20132324 (2015).","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial","volume":"314","author":"Gheorghiade M","year":"2015","unstructured":"Gheorghiade, M. et al. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial. JAMA 314, 2251\u20132262 (2015).","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2015.03.016","article-title":"Cardiovascular drug development: is it dead or just hibernating?","volume":"65","author":"Fordyce CB","year":"2015","unstructured":"Fordyce, C. B. et al. Cardiovascular drug development: is it dead or just hibernating? J Am Coll Cardiol 65, 1567\u20131582 (2015).","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1305500\/v1","author":"Schmidt A","year":"2022","unstructured":"Schmidt, A. et al. Druggable proteins influencing cardiac structure and function: implications for heart failure therapies and cancer related cardiotoxicity. Preprint at https:\/\/doi.org\/10.21203\/rs.3.rs-1305500\/v1 (2022)."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2635-8","article-title":"Genetic and functional insights into the fractal structure of the heart","volume":"584","author":"Meyer HV","year":"2020","unstructured":"Meyer, H. V. et al. Genetic and functional insights into the fractal structure of the heart. Nature 584, 589\u2013594 (2020).","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1093\/eurheartj\/ehab466","article-title":"Genome-wide association study identifies 18 novel loci associated with left atrial volume and function","volume":"42","author":"Ahlberg G","year":"2021","unstructured":"Ahlberg, G. et al. Genome-wide association study identifies 18 novel loci associated with left atrial volume and function. European Heart Journal 42, 4523\u20134534 (2021).","journal-title":"European Heart Journal"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.06.21267389","author":"Wu K-H H","year":"2021","unstructured":"Wu, K.-H. H. et al. Polygenic risk score from a multi-ancestry GWAS uncovers susceptibility of heart failure. 2021.12.06.21267389 Preprint at https:\/\/doi.org\/10.1101\/2021.12.06.21267389 (2021)."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCULATIONAHA.118.035774","article-title":"Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery","volume":"139","author":"Aragam Krishna G","year":"2019","unstructured":"Aragam Krishna G. et al. Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery. Circulation 139, 489\u2013501 (2019).","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/eurheartj\/ehab030","article-title":"Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23","volume":"42","author":"Garnier S","year":"2021","unstructured":"Garnier, S. et al. Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. Eur Heart J 42, 2000\u20132011 (2021).","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","article-title":"Biobank-driven genomic discovery yields new insight into atrial fibrillation biology","volume":"50","author":"Nielsen JB","year":"2018","unstructured":"Nielsen, J. B. et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet 50, 1234\u20131239 (2018).","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/gepi.22077","article-title":"Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables","volume":"41","author":"Burgess S","year":"2017","unstructured":"Burgess, S., Zuber, V., Valdes-Marquez, E., Sun, B. B. & Hopewell, J. C. Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables. Genetic Epidemiology 41, 714\u2013725 (2017).","journal-title":"Genetic Epidemiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden J","year":"2015","unstructured":"Bowden, J., Smith, G. D. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. International Journal of Epidemiology 44, 512\u2013525 (2015).","journal-title":"International Journal of Epidemiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden J","year":"2017","unstructured":"Bowden, J. et al. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Statistics in medicine 36, 1783\u20131802 (2017).","journal-title":"Statistics in medicine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression","volume":"47","author":"Bowden J","year":"2018","unstructured":"Bowden, J. et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol 47, 1264\u20131278 (2018).","journal-title":"Int J Epidemiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates","volume":"64","author":"Storey JD","year":"2002","unstructured":"Storey, J. D. A direct approach to false discovery rates. Journal of the Royal Statistical Society. Series B: Statistical Methodology 64, 479\u2013498 (2002).","journal-title":"Journal of the Royal Statistical Society. Series B: Statistical Methodology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade M","year":"2006","unstructured":"Gheorghiade, M. et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296, 2217\u20132226 (2006).","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/CIRCRESAHA.116.308407","article-title":"Cardioembolic Stroke","volume":"120","author":"Kamel H","year":"2017","unstructured":"Kamel, H. & Healey, J. S. Cardioembolic Stroke. Circulation Research 120, 514\u2013526 (2017).","journal-title":"Circulation Research"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/STROKEAHA.120.028837","article-title":"Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke","volume":"51","author":"Khurshid S","year":"2020","unstructured":"Khurshid, S. et al. Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke. Stroke 51, 1396\u20131403 (2020).","journal-title":"Stroke"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/dc12-0474","article-title":"Right Ventricular Involvement in Diabetic Cardiomyopathy","volume":"36","author":"Widya RL","year":"2013","unstructured":"Widya, R. L. et al. Right Ventricular Involvement in Diabetic Cardiomyopathy. Diabetes Care 36, 457\u2013462 (2013).","journal-title":"Diabetes Care"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(21)00340-9","article-title":"The link between blood pressure and Alzheimer\u2019s disease","volume":"20","author":"DeCarli C","year":"2021","unstructured":"DeCarli, C. The link between blood pressure and Alzheimer\u2019s disease. The Lancet Neurology 20, 878\u2013879 (2021).","journal-title":"The Lancet Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/ije\/dyu187","article-title":"Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits","volume":"43","author":"Silverwood RJ","year":"2014","unstructured":"Silverwood, R. J. et al. Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits. Int J Epidemiol 43, 1781\u20131790 (2014).","journal-title":"Int J Epidemiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/gepi.22041","article-title":"Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization","volume":"41","author":"Staley JR","year":"2017","unstructured":"Staley, J. R. & Burgess, S. Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization. Genet Epidemiol 41, 341\u2013352 (2017).","journal-title":"Genet Epidemiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","author":"Dunlay SM","year":"2019","unstructured":"Dunlay, S. M. et al. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation (2019) doi:10.1161\/CIR.0000000000000691.","journal-title":"Circulation"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2449265\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2449265\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T12:36:29Z","timestamp":1677674189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2449265\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":27,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2449265\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,2,2]]},"subtype":"preprint"}}